Biosimilar Patent Litigation May Be On The Rise In 2020
The Biologics Price Competition and Innovation Act, signed into law as part of the Affordable Care Act in March 2010, established an abbreviated regulatory pathway and unique litigation framework for biosimilars...To view the full article, register now.
Already a subscriber? Click here to view full article